RAPID Earnings|M&A Monday, November 16, 2026 +0.90 Positive

Rapid Micro Biosystems Q3 Revenue Rises

Rapid Micro Biosystems reported Q3 2026 revenue of $9.5 million, up 22%, alongside a record 25.2% gross margin. Meanwhile, the company announced it has entered into a definitive agreement to be acquired by Merck KGaA.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed